Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment
Clinical trial NCT06818721 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06818721
- Sponsor
- Unity Health Toronto
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-04-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.